Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
3.67 USD | -2.65% |
|
-13.97% | -11.47% |
07-01 | Relmada Therapeutics, Inc.(NasdaqGS:RLMD) added to Russell Microcap Growth Index | CI |
07-01 | Relmada Therapeutics, Inc.(NasdaqGS:RLMD) added to Russell 3000E Growth Index | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-11.47% | 114M | |
+19.99% | 126B | |
+23.31% | 118B | |
+23.26% | 27.87B | |
-18.42% | 20.95B | |
-15.13% | 16.92B | |
-13.50% | 16.18B | |
+9.81% | 14.84B | |
-46.10% | 14.79B | |
+51.89% | 14.08B |
- Stock Market
- Equities
- RLMD Stock
- News Relmada Therapeutics, Inc.
- Goldman Sachs Adjusts Relmada Therapeutics' Price Target to $53 from $69, Keeps Buy Rating